Arkolith/Insider Trading/RAPP/Form 4

Gault Cheryl

Chief Operating OfficerRapport Therapeutics, Inc. (RAPP) · full profile →Form 4 · filed Dec 1, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$151K
Net Open-Market Flow
-$151K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 26, 2025Option exercise(M)5K$1.80$9K177K
Nov 26, 2025Sell(S)5K$30.10$151K172K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 26, 2025Option exercise(M)5K—$0105K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-303910) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML